1. LB16. Surveillance Rates of Cefiderocol Heteroresistance Correlate With All-cause Mortality in the APEKS-NP and CREDIBLE-CR Trials. (4th December 2021) Authors: Choby, Jacob E; Ozturk, Tugba; Satola, Sarah W; Jacob, Jesse T; Weiss, David Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LB16. Surveillance Rates of Cefiderocol Heteroresistance Correlate With All-cause Mortality in the APEKS-NP and CREDIBLE-CR Trials. (4th December 2021) Authors: Choby, Jacob E; Ozturk, Tugba; Satola, Sarah W; Jacob, Jesse T; Weiss, David Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens. Issue 5 (May 2021) Authors: Choby, Jacob E; Ozturk, Tugba; Satola, Sarah W; Jacob, Jesse T; Weiss, David S Journal: Lancet infectious diseases Issue: Volume 21:Issue 5(2021) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗